Cargando…

Developing a pan-cancer research autopsy programme

AIMS: Rapid procurement of a wide variety of metastatic and primary cancers and normal tissues after death through rapid autopsy opens largely unexplored avenues in cancer research. We describe a high-volume rapid research autopsy programme at a large academic medical centre. METHODS: Advanced-stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Bavi, Prashant, Siva, Madura, Abi-Saab, Tarek, Chadwick, Dianne, Dhani, Neesha, Butany, Jagdish, Joshua, Anthony M, Roehrl, Michael H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817699/
https://www.ncbi.nlm.nih.gov/pubmed/31262953
http://dx.doi.org/10.1136/jclinpath-2019-205874
_version_ 1783463478795698176
author Bavi, Prashant
Siva, Madura
Abi-Saab, Tarek
Chadwick, Dianne
Dhani, Neesha
Butany, Jagdish
Joshua, Anthony M
Roehrl, Michael H
author_facet Bavi, Prashant
Siva, Madura
Abi-Saab, Tarek
Chadwick, Dianne
Dhani, Neesha
Butany, Jagdish
Joshua, Anthony M
Roehrl, Michael H
author_sort Bavi, Prashant
collection PubMed
description AIMS: Rapid procurement of a wide variety of metastatic and primary cancers and normal tissues after death through rapid autopsy opens largely unexplored avenues in cancer research. We describe a high-volume rapid research autopsy programme at a large academic medical centre. METHODS: Advanced-stage cancer patients, most commonly inpatients in palliative care facilities, were approached to participate in a cancer research autopsy programme with the goal of acquiring multidimensionally annotated tissue for cancer research. On death of an enrolled patient, a predetermined notification plan was enacted, with the medical oncologist/clinical research coordinator informing a team of pathologists, researchers and allied staff. Quality assurance metrics were measured. Thereafter, tissues were annotated in a tissue bioinformatics database and linked to electronic patient records. All banked tissues were reviewed for tumour integrity, including DNA and RNA quality. RESULTS: Over 100 rapid research autopsies from diverse cancer sites were performed, and specimens were procured and annotated with detailed clinical information, including treatment and response. Tissues were successfully enabling studies of tumour immunology, xenografts, genomics and proteomics. CONCLUSIONS: Large-scale rapid procurement and biobanking of cancer tissues from a rapid autopsy programme is feasible. Multidisciplinary integration between health and administrative staff from medical oncology, palliative care, pathology and biospecimen sciences is critical for the success of this challenging endeavour.
format Online
Article
Text
id pubmed-6817699
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-68176992019-11-12 Developing a pan-cancer research autopsy programme Bavi, Prashant Siva, Madura Abi-Saab, Tarek Chadwick, Dianne Dhani, Neesha Butany, Jagdish Joshua, Anthony M Roehrl, Michael H J Clin Pathol Original Article AIMS: Rapid procurement of a wide variety of metastatic and primary cancers and normal tissues after death through rapid autopsy opens largely unexplored avenues in cancer research. We describe a high-volume rapid research autopsy programme at a large academic medical centre. METHODS: Advanced-stage cancer patients, most commonly inpatients in palliative care facilities, were approached to participate in a cancer research autopsy programme with the goal of acquiring multidimensionally annotated tissue for cancer research. On death of an enrolled patient, a predetermined notification plan was enacted, with the medical oncologist/clinical research coordinator informing a team of pathologists, researchers and allied staff. Quality assurance metrics were measured. Thereafter, tissues were annotated in a tissue bioinformatics database and linked to electronic patient records. All banked tissues were reviewed for tumour integrity, including DNA and RNA quality. RESULTS: Over 100 rapid research autopsies from diverse cancer sites were performed, and specimens were procured and annotated with detailed clinical information, including treatment and response. Tissues were successfully enabling studies of tumour immunology, xenografts, genomics and proteomics. CONCLUSIONS: Large-scale rapid procurement and biobanking of cancer tissues from a rapid autopsy programme is feasible. Multidisciplinary integration between health and administrative staff from medical oncology, palliative care, pathology and biospecimen sciences is critical for the success of this challenging endeavour. BMJ Publishing Group 2019-10 2019-07-01 /pmc/articles/PMC6817699/ /pubmed/31262953 http://dx.doi.org/10.1136/jclinpath-2019-205874 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Article
Bavi, Prashant
Siva, Madura
Abi-Saab, Tarek
Chadwick, Dianne
Dhani, Neesha
Butany, Jagdish
Joshua, Anthony M
Roehrl, Michael H
Developing a pan-cancer research autopsy programme
title Developing a pan-cancer research autopsy programme
title_full Developing a pan-cancer research autopsy programme
title_fullStr Developing a pan-cancer research autopsy programme
title_full_unstemmed Developing a pan-cancer research autopsy programme
title_short Developing a pan-cancer research autopsy programme
title_sort developing a pan-cancer research autopsy programme
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817699/
https://www.ncbi.nlm.nih.gov/pubmed/31262953
http://dx.doi.org/10.1136/jclinpath-2019-205874
work_keys_str_mv AT baviprashant developingapancancerresearchautopsyprogramme
AT sivamadura developingapancancerresearchautopsyprogramme
AT abisaabtarek developingapancancerresearchautopsyprogramme
AT chadwickdianne developingapancancerresearchautopsyprogramme
AT dhanineesha developingapancancerresearchautopsyprogramme
AT butanyjagdish developingapancancerresearchautopsyprogramme
AT joshuaanthonym developingapancancerresearchautopsyprogramme
AT roehrlmichaelh developingapancancerresearchautopsyprogramme